The role of TCF7L2 in hepatic glucose metabolism in vivo
The role of TCF7L2 in hepatic glucose metabolism in vivo
批准号:
8700710
负责人:
Luke Norton
金额:
$10.97万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-15 至 2017-03-31
关键词:
AddressAdenovirusesAdultAffectAllelesAreaBindingBioinformaticsBlood GlucoseBlood VesselsCandidate Disease GeneCellsComputational TechniqueCoupledDataDefectDevelopmentDevelopment PlansDiabetes MellitusDiseaseEnvironmentEpidemicEuglycemic ClampingFailureFastingFigs - dietaryFoundationsFutureGene ExpressionGene Expression RegulationGene TargetingGenesGenetic TranscriptionGenomicsGlucose ClampGoalsHepaticHepatocyteHumanHyperglycemiaIn VitroIndividualInsulin ResistanceInvestigationKnowledgeLaboratory FindingLeadLiverMentorsMetabolicMetabolic PathwayMindMolecularMolecular BiologyMolecular GeneticsMorbidity - disease rateMusNon-Insulin-Dependent Diabetes MellitusOGTTPancreasPathogenesisPathway interactionsPatientsPhysiologicalPhysiological ProcessesPhysiologyPlayPopulationPublishingRadioisotopesRattusRegulationRegulator GenesResearchRiskRisk FactorsRoleSingle Nucleotide PolymorphismSolidSusceptibility GeneTechnologyTestingTimeTissuesTracerTrainingTraining ActivityTranscriptional RegulationTranslational Researchblood glucose regulationcareercareer developmentclinically significantdesigndiabetic patientfunctional genomicsgenome wide association studyglucose metabolismglucose productionglucose tolerancehuman TCF7L2 proteinin vivoinsulin sensitivityinterestnovelprogramspublic health relevanceresearch studyskillstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Single-nucleotide polymorphisms (SNP) within the transcription factor 7-like 2 (TCF7L2) gene have been consistently associated with an elevated risk for type 2 diabetes (T2DM) in multiple populations throughout the world, but the mechanisms by which TCF7L2 affects the pathways important for the development of T2DM are still poorly understood. Addressing this question is of major importance, primarily because functional investigations into T2DM candidate genes will reveal novel molecular pathways that affect important physiological processes that are highly disturbed in T2DM. In several human studies, carriers of the T-allele for the "at-risk" SNP (rs7903146) have impaired hepatic glucose production (HGP) and hepatic insulin sensitivity. Preliminary findings from the laboratory of Dr Norton demonstrating that silencing of TCF7L2 markedly up- regulates HGP in vitro, strongly support a role for TCF7L2 in the pathways of HGP. The aim of this proposal is to establish the functional role of the T2DM candidate gene TCF7L2 in HGP in vivo, and to investigate the molecular mechanisms by which TCF7L2 affects the pathways of glucose metabolism in the liver. A combination of integrative physiology and genomics approaches will be used to address the central hypothesis that TCF7L2 is a major regulator of HGP in vivo and that transcriptional control of key metabolic genes by TCF7L2 in the liver is the underlying mechanism of this regulation. The major training component of this proposal is the acquisition, refinement and application of new skills, with focus on two areas: (i) integrated physiology, and (ii) functional genomics and bioinformatics. These thematic areas were selected because at the present time knowledge about these areas is extremely valuable to conduct cutting-edge diabetes research, and these areas are cohesive and highly integrated with the scientific goals of this project. In addition, the scientific objectives of this proposal will be coupled with an intensive career development plan that will include formal coursework in grantsmanship and translational science. The Diabetes Division at the UTHSCSA, chaired by the mentor on this project Dr DeFronzo, is the ideal environment in which to perform this research and to further enhance Dr Norton's expertise in diabetes research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Regulation of Hepatic Metabolic Zonation by the Diabetes Gene TCF7L2
-
批准号:10542424
-
项目类别:
-
资助金额:$48.94万
-
财政年份:2022
-
负责人:Luke Norton
-
依托单位:
The Regulation of Hepatic Metabolic Zonation by the Diabetes Gene TCF7L2
-
批准号:10369409
-
项目类别:
-
资助金额:$44.09万
-
财政年份:2022
-
负责人:Luke Norton
-
依托单位:
The role of TCF7L2 in hepatic glucose metabolism in vivo
-
批准号:9039586
-
项目类别:
-
资助金额:$10.97万
-
财政年份:2014
-
负责人:Luke Norton
-
依托单位:
海外基金